Harvey Karpo, DPM
Primary Podiatric Medicine · Woodbury, NJNPI 1972531242
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Paragon 28, Inc. at 54.8% of the total. Reporting peaked in 2021 at $2,500 and has fallen 74.8% since, to $630 in 2024.
Across 22 payments — averaging $207.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$3K
- AbbVie$555
- Averitas Pharma Inc.$250
- Abbott$154
- Medtronic$150
- Paratek Pharmaceuticals, Inc.$125
- plus $826 from 8 others
What the payments were for
- Grants$2,50055%
- Food & beverage$2,05945%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 1 | $2,500 |
| AbbVie | 8 | $555 |
| Averitas Pharma Inc. | 2 | $250 |
| Abbott | 1 | $154 |
| Medtronic | 1 | $150 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Amgen | 1 | $120 |
| ANI Pharmaceuticals, Inc. | 1 | $118 |
| Inari Medical, Inc. | 1 | $117 |
| Zimmer Biomet | 1 | $106 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $100 |
| Smith+Nephew | 1 | $98 |
| Nevro Corp. | 1 | $91 |
| GRT US Holding, Inc. | 1 | $75 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$250
- PROCLAIM$154
- INTELLIS ADAPTIVESTIM$150
- NUZYRA$125
- KRYSTEXXA$120
- PURIFIED CORTROPHIN GEL$118
- FLOWTRIEVER CATHETER, S$117
- CT THROMBECTOMY SYSTEM KIT$117
- Nextremity MSP$106
How this compares
$4,559 in reported general payments places this provider in the 85th percentile of 45 primary podiatric medicine providers in New Jersey.
See all primary podiatric medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 11 | $235 |
| Betamethasone Valerate | 17 | $207 |
| Ammonium Lactate | 11 | $158 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Woodbury
- Stephanie ExleyWoodbury$2K
- Lori LewisWoodbury$427
- Andrew BloomEnglewood$14K
- Paul KleinWayne$6K
- Jessica AddeoHowell$5K
- Alicia LaiLinwood$5K
- Adenike SonaikeFair Lawn$5K
- Melissa ShinderMount Laurel$3K
- Richard MunozDover$3K
- Richard FilipekGarfield$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.